A5052779999- Mitochondrial Function and Pathology
- Genetic Neurodegenerative Diseases
- DNA Repair Mechanisms
- Neurological disorders and treatments
- Cancer Treatment and Pharmacology
- Neuroscience and Neural Engineering
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease and Spinal Disorders
- Myasthenia Gravis and Thymoma
Prisma Health
2021-2023
University of South Carolina
2023
Oregon Health & Science University
2020-2021
PolyQ ATXN3 is a pharmacodynamic marker for SCA3, and SNP associated with the expanded allele may serve to specifically target mutant .
Traditionally, the standard of care for medication refractory essential tremor has been to utilize omnidirectional deep brain stimulation ventral intermediate nucleus. The advent directional allows spatial restriction on selected targets without involving neighboring structures, thereby limiting off-target side effects and improving clinical utility.We performed a retrospective review patients between February 2017 September 2019 who had received nucleus that allowed programming...
<h3>Objective:</h3> We present a unique clinical case of antibody positive Muscle Specific Kinase (MuSK) Myasthenia Gravis and DaT scan Parkinson's Disease to highlight the overlapping nature symptoms challenges seen in diagnosis. <h3>Background:</h3> The concomitant diagnosis (MG), an autoimmune condition that affects neuromuscular junction, disease (PD), neurodegenerative basal ganglia, is remarkably exceptional. Furthermore, there are very few reports literature have recognized...